Organisation paid for research Program year 2025 Source: CMS Open Payments

L Marc Research Center

Neither a doctor nor a teaching hospital

Research payments

$1,089,619

2,494 payments

Through program year 2025, L Marc Research Center is reported as receiving $1,089,619 in research payments, across 2,494 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$43,337	11
2024	Research	$99,565	69
2023	Research	$213,720	336
2022	Research	$236,123	785
2021	Research	$205,741	836
2020	Research	$246,422	435
2019	Research	$44,712	22

Breakdown

Who paid Research payments · program years 2019–2025

Novo Nordisk AS $1,017,762 2,460 payments
Regeneron Pharmaceuticals, Inc. $45,313 25 payments
Allergan Inc. $16,233 7 payments
AbbVie, Inc. $7,968 1 payment
Merck Sharp & Dohme Corporation $2,343 1 payment

Studies the money was for Research payments · program years 2019–2025

Ex9924-4473 $342,437 748 payments
Ex9536-4388 $297,330 562 payments
Nn9535-4352 $160,777 418 payments
Nn9536-4578 $82,914 396 payments
Nn9536-4373 $37,438 14 payments
Nn9535-4506 $31,536 29 payments
Nn9924-4635 $24,987 52 payments
Long Term Safety Study of PRALUENT in Patients With Heterozygous Familial Hypercholesterolemia or With Non-Familial Hypercholesterolemia at High and Very High Cardiovascular Risk and Previously Enrolled in the Neurocognitive Function Trial $19,679 11 payments
A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Longterm Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Patients With Episodic Migraine $16,008 6 payments
Nn9536-4376 $14,596 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.